Harvard Bioscience Inc logo

HBIO

Technology

Harvard Bioscience Inc

$7.24+0.61 (+9.20%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving HBIO Today?

No stock-specific AI insight has been generated for HBIO yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$33M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume151K
Avg Volume (10D)
Shares Outstanding4.5M

HBIO News

20 articles

All 20 articles loaded

Price Data

Open$6.41
Previous Close$6.63
Day High$6.75
Day Low$6.41
52 Week High
52 Week Low

About Harvard Bioscience Inc

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

339 employees
Listed December 7, 2000
TechnologyLABORATORY ANALYTICAL INSTRUMENTS

Company Details

Security TypeStock
ExchangeNASDAQ
Currency
Round Lot
SICLABORATORY ANALYTICAL INSTRUMENTS
CIK
Composite FIGI
Share Class FIGI